GlassScriptPhysician profile
Amanpreet Kaur
NPI 1972894087
$2,508.69
in general payments reported to CMS, 2019-2025
23 companies · $51.56 in 2025
The $51.56 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $340 · 2021: $201 · 2022: $224 · 2023: $209 · 2024: $185 · 2025: $51.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.03 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $917.18 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $284.12 | 2019-2023 | Breztri, Airsupra |
| Genentech USA, INC. | $250.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.97 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $122.80 | 2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $115.94 | 2019 | |
| Abbott Laboratories | $100.83 | 2023 | Xact |
| Amarin Pharma, INC. | $99.06 | 2019 | |
| Novo Nordisk INC | $90.69 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $63.26 | 2019-2020 | |
| Amgen INC. | $59.51 | 2019-2023 | Tezspire |
| Medtronic, INC. | $31.23 | 2022 | |
| Cardiovascular Systems INC. | $26.76 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $25.86 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Zerbaxa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $23.06 | 2024 | |
| Genzyme Corporation | $19.78 | 2024 | |
| Inogen, INC. | $19.70 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Harmony Biosciences LLC | $19.22 | 2024 | |
| Olympus America INC. | $16.04 | 2023 | Evis Exera II Ultrasonic Bronchofibervideoscope, Oes Bronchofiberscope |
| Astellas Pharma US INC | $15.65 | 2020 | |
| Advanced Respiratory, INC | $14.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.